Mechanisms of Osteoblastic Bone Metastasis in Prostate Cancer: Role of Prostatic Acid Phosphatase
暂无分享,去创建一个
S. Izadmehr | A. Levine | A. Kirschenbaum | Dushyanthy Arumugam | Mariana Quiroz-Munoz | Beatrice Y Wong
[1] M. Murshed. Mechanism of Bone Mineralization. , 2018, Cold Spring Harbor perspectives in medicine.
[2] A. Villers,et al. TMPRSS2:ERG gene fusion expression regulates bone markers and enhances the osteoblastic phenotype of prostate cancer bone metastases. , 2018, Cancer letters.
[3] Y. Tabata,et al. Coupling of bone resorption and formation by RANKL reverse signalling , 2018, Nature.
[4] H. Leong,et al. Translational models of prostate cancer bone metastasis , 2018, Nature Reviews Urology.
[5] U. Lerner,et al. Inhibition of the insulin-like growth factor-1 receptor potentiates acute effects of castration in a rat model for prostate cancer growth in bone , 2017, Clinical & Experimental Metastasis.
[6] S. Izadmehr,et al. Prostatic Acid Phosphatase Alters the RANKL/OPG System and Induces Osteoblastic Prostate Cancer Bone Metastases. , 2016, Endocrinology.
[7] César L. Araujo,et al. Transmembrane prostatic acid phosphatase (TMPAP) delays cells in G1 phase of the cell cycle , 2016, The Prostate.
[8] V. Labas,et al. Quantitative proteomics provides new insights into chicken eggshell matrix protein functions during the primary events of mineralisation and the active calcification phase. , 2015, Journal of proteomics.
[9] C. Thoma. Prostate cancer: Targeting the FGFR curbs bone metastasis , 2014, Nature Reviews Urology.
[10] R. Randall. A Promise to Our Patients with Metastatic Bone Disease , 2014, Annals of surgical oncology.
[11] T. Rosol,et al. Review of Animal Models of Prostate Cancer Bone Metastasis , 2014 .
[12] P. Nelson,et al. Prostate cancer derived prostatic acid phosphatase promotes an osteoblastic response in the bone microenvironment , 2014, Clinical & Experimental Metastasis.
[13] M. Bernards,et al. Mineralization induction effects of osteopontin, bone sialoprotein, and dentin phosphoprotein on a biomimetic collagen substrate. , 2013, Journal of biomedical materials research. Part A.
[14] B. Cronstein,et al. Adenosine and bone metabolism , 2013, Trends in Endocrinology & Metabolism.
[15] B. Evans,et al. An emerging role for adenosine and its receptors in bone homeostasis , 2012, Front. Endocrin..
[16] G. Manning,et al. The Raine Syndrome Protein FAM20C Is a Golgi Kinase That Phosphorylates Bio-Mineralization Proteins , 2012, PloS one.
[17] T. Guise,et al. The role of TGF-β in bone metastasis: novel therapeutic perspectives. , 2012, BoneKEy reports.
[18] Lisa N Kinch,et al. Secreted Kinase Phosphorylates Extracellular Proteins That Regulate Biomineralization , 2012, Science.
[19] N. Sträter,et al. Cellular function and molecular structure of ecto-nucleotidases , 2012, Purinergic Signalling.
[20] K. Ravid,et al. A2B Adenosine Receptor Promotes Mesenchymal Stem Cell Differentiation to Osteoblasts and Bone Formation in Vivo* , 2012, The Journal of Biological Chemistry.
[21] A. Leiter,et al. Prostatic acid phosphatase is expressed in human prostate cancer bone metastases and promotes osteoblast differentiation , 2011, Annals of the New York Academy of Sciences.
[22] J. Waxman,et al. Bone metastasis in prostate cancer: emerging therapeutic strategies , 2011, Nature Reviews Clinical Oncology.
[23] J. Waxman,et al. Bone metastasis in prostate cancer: emerging therapeutic strategies , 2011, Nature Reviews Clinical Oncology.
[24] M. Carducci,et al. Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study , 2011, The Lancet.
[25] C. Nieder,et al. Anaemia and thrombocytopenia in patients with prostate cancer and bone metastases , 2010, BMC Cancer.
[26] Yaping Tu,et al. Human Prostatic Acid Phosphatase, an Authentic Tyrosine Phosphatase, Dephosphorylates ErbB-2 and Regulates Prostate Cancer Cell Growth* , 2010, The Journal of Biological Chemistry.
[27] B. Fredholm,et al. Adenosine A(1) receptors regulate bone resorption in mice: adenosine A(1) receptor blockade or deletion increases bone density and prevents ovariectomy-induced bone loss in adenosine A(1) receptor-knockout mice. , 2010, Arthritis and rheumatism.
[28] D. Waddington,et al. New hypotheses on the function of the avian shell gland derived from microarray analysis comparing tissue from juvenile and sexually mature hens. , 2009, General and comparative endocrinology.
[29] H. Zimmermann. Prostatic acid phosphatase, a neglected ectonucleotidase , 2009, Purinergic Signalling.
[30] B. Clarke,et al. Normal bone anatomy and physiology. , 2008, Clinical journal of the American Society of Nephrology : CJASN.
[31] W. Fu,et al. Osteoblasts‐derived BMP‐2 enhances the motility of prostate cancer cells via activation of integrins , 2008, The Prostate.
[32] Kent Wallner,et al. Reviving the acid phosphatase test for prostate cancer. , 2007, Oncology.
[33] A. Levine,et al. Androgen-induced Wnt signaling in preosteoblasts promotes the growth of MDA-PCa-2b human prostate cancer cells. , 2007, Cancer research.
[34] J. Chirgwin,et al. Basic Mechanisms Responsible for Osteolytic and Osteoblastic Bone Metastases , 2006, Clinical Cancer Research.
[35] S. Berry,et al. The use of bisphosphonates in men with hormone-refractory prostate cancer: a systematic review of randomized trials. , 2006, The Canadian journal of urology.
[36] O. MacDougald,et al. Role of wnts in prostate cancer bone metastases , 2006, Journal of cellular biochemistry.
[37] J. Nelson,et al. The endothelin axis: emerging role in cancer , 2003, Nature Reviews Cancer.
[38] C. Huggins,et al. Studies on prostatic cancer. I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941. , 2002, The Journal of urology.
[39] E. Luchter-Wasylewska. Cooperative kinetics of human prostatic acid phosphatase. , 2001, Biochimica et biophysica acta.
[40] A. Mizokami,et al. Osteoprotegerin inhibits prostate cancer-induced osteoclastogenesis and prevents prostate tumor growth in the bone. , 2001, The Journal of clinical investigation.
[41] K. Pienta,et al. VCaP, a cell-based model system of human prostate cancer. , 2001, In vivo.
[42] L. Chung,et al. LNCaP progression model of human prostate cancer: Androgen‐independence and osseous metastasis , 2000, The Prostate.
[43] H. Moch,et al. Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. , 2000, Human pathology.
[44] L. Lebioda,et al. Crystal structure of human prostatic acid phosphatase , 2000, The Prostate.
[45] C. Kao,et al. Establishing human prostate cancer cell xenografts in bone: Induction of osteoblastic reaction by prostate‐specific antigen‐producing tumors in athymic and SCID/bg mice using LNCaP and lineage‐derived metastatic sublines , 1998, International journal of cancer.
[46] M. Mazumdar,et al. Acid phosphatase: defining a role in androgen-independent prostate cancer. , 1996, Urology.
[47] J. Puzas,et al. Human prostatic acid phosphatase directly stimulates collagen synthesis and alkaline phosphatase content of isolated bone cells. , 1991, The Journal of clinical endocrinology and metabolism.
[48] A. Bilska,et al. Is the subunit of prostatic phosphatase active? Reversible denaturation of prostatic acid phosphatase. , 1990, Biochemistry international.
[49] J. Lechner,et al. Establishment and characterization of a human prostatic carcinoma cell line (PC-3). , 1979, Investigative urology.
[50] D. Paulson,et al. Isolation of a human prostate carcinoma cell line (DU 145) , 1978, International journal of cancer.
[51] H. Abrams. Skeletal metastases in carcinoma. , 1950, Radiology.
[52] C. Huggins,et al. Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate , 1941, CA: a cancer journal for clinicians.
[53] E. Sproul,et al. Significance of Increased Phosphatase Activity of Bone at the Site of Osteoplastic Metastases Secondary to Carcinoma of the Prostate Gland , 1936 .
[54] S Paget,et al. THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST. , 1889 .
[55] A. Jemal,et al. Cancer statistics, 2018 , 2018, CA: a cancer journal for clinicians.
[56] S. Sheng. The Urokinase-type Plasminogen Activator System in Prostate Cancer Metastasis , 2004, Cancer and Metastasis Reviews.
[57] J. Chernoff,et al. A phosphotyrosyl-protein phosphatase activity associated with acid phosphatase from human prostate gland. , 1984, European journal of biochemistry.
[58] S. Arya,et al. The LNCaP cell line--a new model for studies on human prostatic carcinoma. , 1980, Progress in clinical and biological research.